RE:RE:RE:+Efficacy Results in STEM Pet Oral Care Clinical TrialAll the wheels of this company are turning, the management group is solid with partners in place, products have an exclusive niche, attention is being received from the US army, research grants in place, deals are transparent, large market, growing revenues, solid financials and a strategic plan in place. Investor awareness is low and desire for new retail stock owners to purchase stock is stymied by a minimal social media presence and awareness of potential here. Getting attention of new investors should receive the same priority as other business functions imho. Creating a dedicated, experienced, working group or team to develop awareness and compete against other BioTech for the investment dollar needs to be top line as well. The increased market cap willl open up tremendous opportunities and gain attention of institutional investors. Most large funds will not touch any stock under a 1-5 dollars. So attract new investors or reverse split to bring up share price. Hiring a market maker isn't enough when share demand is low and there is little awareness. The only other hopeful is a buyout from an existing partner.